The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global IgG2b Antibody Market Research Report 2025

Global IgG2b Antibody Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1897612

No of Pages : 104

Synopsis
IgG2b Antibody is a subclass of the IgG antibody, one of the major classes of antibodies produced by the immune system. IgG2b antibodies are involved in immune responses by recognizing and neutralizing foreign substances such as bacteria and viruses. This subclass of IgG antibodies is known for its ability to activate complement, a part of the immune system that helps to destroy pathogens. IgG2b antibodies are commonly used in research and diagnostic applications to study immune responses and detect the presence of certain diseases.
The global IgG2b Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for IgG2b Antibody has experienced growth due to its importance in immunology research and diagnostics. These antibodies are essential for understanding the humoral immune response and have significant applications in the development of vaccines, therapeutic antibodies, and diagnostic tests. The potential for IgG2b Antibody in personalized medicine and precision diagnostics is expected to drive the industry trend forward. As the field of immunology continues to advance, the use of IgG2b Antibody in research and potential clinical applications is likely to remain strong.
This report aims to provide a comprehensive presentation of the global market for IgG2b Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IgG2b Antibody.
Report Scope
The IgG2b Antibody market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IgG2b Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IgG2b Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
MyBioSource
Novus Biologicals
BosterBio
RayBiotech
Biorbyt
Bio X Cell
Abeomics
Cell Sciences
SouthernBiotech
Thermo Fisher Scientific
Miltenyi Biotec
R&D Systems
Wuhan Fine Biotech
BioLegend
LI-COR Biosciences
ichorbio
Proteintech
OriGene Technologies
Aviva Systems Biology
Antigenix America
LSBio
Tonbo Biosciences
BPS Bioscience
IBL
Merck
GeneTex
NSJ Bioreagents
Mabtech
American Research Products
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IgG2b Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IgG2b Antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global IgG2b Antibody Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IgG2b Antibody Market Perspective (2019-2030)
2.2 IgG2b Antibody Growth Trends by Region
2.2.1 Global IgG2b Antibody Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IgG2b Antibody Historic Market Size by Region (2019-2024)
2.2.3 IgG2b Antibody Forecasted Market Size by Region (2025-2030)
2.3 IgG2b Antibody Market Dynamics
2.3.1 IgG2b Antibody Industry Trends
2.3.2 IgG2b Antibody Market Drivers
2.3.3 IgG2b Antibody Market Challenges
2.3.4 IgG2b Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IgG2b Antibody Players by Revenue
3.1.1 Global Top IgG2b Antibody Players by Revenue (2019-2024)
3.1.2 Global IgG2b Antibody Revenue Market Share by Players (2019-2024)
3.2 Global IgG2b Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IgG2b Antibody Revenue
3.4 Global IgG2b Antibody Market Concentration Ratio
3.4.1 Global IgG2b Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IgG2b Antibody Revenue in 2023
3.5 IgG2b Antibody Key Players Head office and Area Served
3.6 Key Players IgG2b Antibody Product Solution and Service
3.7 Date of Enter into IgG2b Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IgG2b Antibody Breakdown Data by Type
4.1 Global IgG2b Antibody Historic Market Size by Type (2019-2024)
4.2 Global IgG2b Antibody Forecasted Market Size by Type (2025-2030)
5 IgG2b Antibody Breakdown Data by Application
5.1 Global IgG2b Antibody Historic Market Size by Application (2019-2024)
5.2 Global IgG2b Antibody Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IgG2b Antibody Market Size (2019-2030)
6.2 North America IgG2b Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America IgG2b Antibody Market Size by Country (2019-2024)
6.4 North America IgG2b Antibody Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IgG2b Antibody Market Size (2019-2030)
7.2 Europe IgG2b Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe IgG2b Antibody Market Size by Country (2019-2024)
7.4 Europe IgG2b Antibody Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IgG2b Antibody Market Size (2019-2030)
8.2 Asia-Pacific IgG2b Antibody Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific IgG2b Antibody Market Size by Region (2019-2024)
8.4 Asia-Pacific IgG2b Antibody Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IgG2b Antibody Market Size (2019-2030)
9.2 Latin America IgG2b Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America IgG2b Antibody Market Size by Country (2019-2024)
9.4 Latin America IgG2b Antibody Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IgG2b Antibody Market Size (2019-2030)
10.2 Middle East & Africa IgG2b Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa IgG2b Antibody Market Size by Country (2019-2024)
10.4 Middle East & Africa IgG2b Antibody Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Detail
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad IgG2b Antibody Introduction
11.1.4 Bio-Rad Revenue in IgG2b Antibody Business (2019-2024)
11.1.5 Bio-Rad Recent Development
11.2 MyBioSource
11.2.1 MyBioSource Company Detail
11.2.2 MyBioSource Business Overview
11.2.3 MyBioSource IgG2b Antibody Introduction
11.2.4 MyBioSource Revenue in IgG2b Antibody Business (2019-2024)
11.2.5 MyBioSource Recent Development
11.3 Novus Biologicals
11.3.1 Novus Biologicals Company Detail
11.3.2 Novus Biologicals Business Overview
11.3.3 Novus Biologicals IgG2b Antibody Introduction
11.3.4 Novus Biologicals Revenue in IgG2b Antibody Business (2019-2024)
11.3.5 Novus Biologicals Recent Development
11.4 BosterBio
11.4.1 BosterBio Company Detail
11.4.2 BosterBio Business Overview
11.4.3 BosterBio IgG2b Antibody Introduction
11.4.4 BosterBio Revenue in IgG2b Antibody Business (2019-2024)
11.4.5 BosterBio Recent Development
11.5 RayBiotech
11.5.1 RayBiotech Company Detail
11.5.2 RayBiotech Business Overview
11.5.3 RayBiotech IgG2b Antibody Introduction
11.5.4 RayBiotech Revenue in IgG2b Antibody Business (2019-2024)
11.5.5 RayBiotech Recent Development
11.6 Biorbyt
11.6.1 Biorbyt Company Detail
11.6.2 Biorbyt Business Overview
11.6.3 Biorbyt IgG2b Antibody Introduction
11.6.4 Biorbyt Revenue in IgG2b Antibody Business (2019-2024)
11.6.5 Biorbyt Recent Development
11.7 Bio X Cell
11.7.1 Bio X Cell Company Detail
11.7.2 Bio X Cell Business Overview
11.7.3 Bio X Cell IgG2b Antibody Introduction
11.7.4 Bio X Cell Revenue in IgG2b Antibody Business (2019-2024)
11.7.5 Bio X Cell Recent Development
11.8 Abeomics
11.8.1 Abeomics Company Detail
11.8.2 Abeomics Business Overview
11.8.3 Abeomics IgG2b Antibody Introduction
11.8.4 Abeomics Revenue in IgG2b Antibody Business (2019-2024)
11.8.5 Abeomics Recent Development
11.9 Cell Sciences
11.9.1 Cell Sciences Company Detail
11.9.2 Cell Sciences Business Overview
11.9.3 Cell Sciences IgG2b Antibody Introduction
11.9.4 Cell Sciences Revenue in IgG2b Antibody Business (2019-2024)
11.9.5 Cell Sciences Recent Development
11.10 SouthernBiotech
11.10.1 SouthernBiotech Company Detail
11.10.2 SouthernBiotech Business Overview
11.10.3 SouthernBiotech IgG2b Antibody Introduction
11.10.4 SouthernBiotech Revenue in IgG2b Antibody Business (2019-2024)
11.10.5 SouthernBiotech Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Detail
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific IgG2b Antibody Introduction
11.11.4 Thermo Fisher Scientific Revenue in IgG2b Antibody Business (2019-2024)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Miltenyi Biotec
11.12.1 Miltenyi Biotec Company Detail
11.12.2 Miltenyi Biotec Business Overview
11.12.3 Miltenyi Biotec IgG2b Antibody Introduction
11.12.4 Miltenyi Biotec Revenue in IgG2b Antibody Business (2019-2024)
11.12.5 Miltenyi Biotec Recent Development
11.13 R&D Systems
11.13.1 R&D Systems Company Detail
11.13.2 R&D Systems Business Overview
11.13.3 R&D Systems IgG2b Antibody Introduction
11.13.4 R&D Systems Revenue in IgG2b Antibody Business (2019-2024)
11.13.5 R&D Systems Recent Development
11.14 Wuhan Fine Biotech
11.14.1 Wuhan Fine Biotech Company Detail
11.14.2 Wuhan Fine Biotech Business Overview
11.14.3 Wuhan Fine Biotech IgG2b Antibody Introduction
11.14.4 Wuhan Fine Biotech Revenue in IgG2b Antibody Business (2019-2024)
11.14.5 Wuhan Fine Biotech Recent Development
11.15 BioLegend
11.15.1 BioLegend Company Detail
11.15.2 BioLegend Business Overview
11.15.3 BioLegend IgG2b Antibody Introduction
11.15.4 BioLegend Revenue in IgG2b Antibody Business (2019-2024)
11.15.5 BioLegend Recent Development
11.16 LI-COR Biosciences
11.16.1 LI-COR Biosciences Company Detail
11.16.2 LI-COR Biosciences Business Overview
11.16.3 LI-COR Biosciences IgG2b Antibody Introduction
11.16.4 LI-COR Biosciences Revenue in IgG2b Antibody Business (2019-2024)
11.16.5 LI-COR Biosciences Recent Development
11.17 ichorbio
11.17.1 ichorbio Company Detail
11.17.2 ichorbio Business Overview
11.17.3 ichorbio IgG2b Antibody Introduction
11.17.4 ichorbio Revenue in IgG2b Antibody Business (2019-2024)
11.17.5 ichorbio Recent Development
11.18 Proteintech
11.18.1 Proteintech Company Detail
11.18.2 Proteintech Business Overview
11.18.3 Proteintech IgG2b Antibody Introduction
11.18.4 Proteintech Revenue in IgG2b Antibody Business (2019-2024)
11.18.5 Proteintech Recent Development
11.19 OriGene Technologies
11.19.1 OriGene Technologies Company Detail
11.19.2 OriGene Technologies Business Overview
11.19.3 OriGene Technologies IgG2b Antibody Introduction
11.19.4 OriGene Technologies Revenue in IgG2b Antibody Business (2019-2024)
11.19.5 OriGene Technologies Recent Development
11.20 Aviva Systems Biology
11.20.1 Aviva Systems Biology Company Detail
11.20.2 Aviva Systems Biology Business Overview
11.20.3 Aviva Systems Biology IgG2b Antibody Introduction
11.20.4 Aviva Systems Biology Revenue in IgG2b Antibody Business (2019-2024)
11.20.5 Aviva Systems Biology Recent Development
11.21 Antigenix America
11.21.1 Antigenix America Company Detail
11.21.2 Antigenix America Business Overview
11.21.3 Antigenix America IgG2b Antibody Introduction
11.21.4 Antigenix America Revenue in IgG2b Antibody Business (2019-2024)
11.21.5 Antigenix America Recent Development
11.22 LSBio
11.22.1 LSBio Company Detail
11.22.2 LSBio Business Overview
11.22.3 LSBio IgG2b Antibody Introduction
11.22.4 LSBio Revenue in IgG2b Antibody Business (2019-2024)
11.22.5 LSBio Recent Development
11.23 Tonbo Biosciences
11.23.1 Tonbo Biosciences Company Detail
11.23.2 Tonbo Biosciences Business Overview
11.23.3 Tonbo Biosciences IgG2b Antibody Introduction
11.23.4 Tonbo Biosciences Revenue in IgG2b Antibody Business (2019-2024)
11.23.5 Tonbo Biosciences Recent Development
11.24 BPS Bioscience
11.24.1 BPS Bioscience Company Detail
11.24.2 BPS Bioscience Business Overview
11.24.3 BPS Bioscience IgG2b Antibody Introduction
11.24.4 BPS Bioscience Revenue in IgG2b Antibody Business (2019-2024)
11.24.5 BPS Bioscience Recent Development
11.25 IBL
11.25.1 IBL Company Detail
11.25.2 IBL Business Overview
11.25.3 IBL IgG2b Antibody Introduction
11.25.4 IBL Revenue in IgG2b Antibody Business (2019-2024)
11.25.5 IBL Recent Development
11.26 Merck
11.26.1 Merck Company Detail
11.26.2 Merck Business Overview
11.26.3 Merck IgG2b Antibody Introduction
11.26.4 Merck Revenue in IgG2b Antibody Business (2019-2024)
11.26.5 Merck Recent Development
11.27 GeneTex
11.27.1 GeneTex Company Detail
11.27.2 GeneTex Business Overview
11.27.3 GeneTex IgG2b Antibody Introduction
11.27.4 GeneTex Revenue in IgG2b Antibody Business (2019-2024)
11.27.5 GeneTex Recent Development
11.28 NSJ Bioreagents
11.28.1 NSJ Bioreagents Company Detail
11.28.2 NSJ Bioreagents Business Overview
11.28.3 NSJ Bioreagents IgG2b Antibody Introduction
11.28.4 NSJ Bioreagents Revenue in IgG2b Antibody Business (2019-2024)
11.28.5 NSJ Bioreagents Recent Development
11.29 Mabtech
11.29.1 Mabtech Company Detail
11.29.2 Mabtech Business Overview
11.29.3 Mabtech IgG2b Antibody Introduction
11.29.4 Mabtech Revenue in IgG2b Antibody Business (2019-2024)
11.29.5 Mabtech Recent Development
11.30 American Research Products
11.30.1 American Research Products Company Detail
11.30.2 American Research Products Business Overview
11.30.3 American Research Products IgG2b Antibody Introduction
11.30.4 American Research Products Revenue in IgG2b Antibody Business (2019-2024)
11.30.5 American Research Products Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’